These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Outcome of portal-systemic shunt surgery for portal hypertension associated with intrahepatic obstruction in patients with agnogenic myeloid metaplasia. Tefferi A, Barrett SM, Silverstein MN, Nagorney DM. Am J Hematol; 1994 Aug; 46(4):325-8. PubMed ID: 8037184 [Abstract] [Full Text] [Related]
31. Correlations of portal hypertensive gastropathy of hepatitis B cirrhosis with other factors. Pan WD, Xun RY, Chen YM. Hepatobiliary Pancreat Dis Int; 2002 Nov 01; 1(4):527-31. PubMed ID: 14607680 [Abstract] [Full Text] [Related]
33. The role of granulomatous phlebitis and thrombosis in the pathogenesis of cirrhosis and portal hypertension in sarcoidosis. Moreno-Merlo F, Wanless IR, Shimamatsu K, Sherman M, Greig P, Chiasson D. Hepatology; 1997 Sep 01; 26(3):554-60. PubMed ID: 9303482 [Abstract] [Full Text] [Related]
35. Endothelial dysfunction in the regulation of cirrhosis and portal hypertension. Iwakiri Y. Liver Int; 2012 Feb 01; 32(2):199-213. PubMed ID: 21745318 [Abstract] [Full Text] [Related]
36. Myeloid metaplasia, perisinusoidal fibrosis, and nodular regenerative hyperplasia of the liver. Degott C, Capron JP, Bettan L, Molas G, Bernuau D, Potet F, Feldmann G, Benhamou JP. Liver; 1985 Oct 01; 5(5):276-81. PubMed ID: 4079668 [Abstract] [Full Text] [Related]